Before serving as CEO of Reva Medical, Ms. Groves served as Vice President and General Manager of the AF Solutions, Cardiac Rhythm and Heart Failure division of Medtronic, a leading global medical technology company. In this position, she successfully developed and executed strategies to re-enter the catheter-based Atrial Fibrillation ablation market and achieved the goal to be market leader in paroxysmal, or intermittent, AF ablation. The role also allowed her to successfully acquire and integrate companies, complete numerous clinical trials, and launch novel products in the US and worldwide. Prior to this, she was the Vice President of Quality and Regulatory for Medtronic’s Cardiac Rhythm Disease Management (“CRDM”) business from 2006 to 2008 and before that was Vice President and General Manager for Patient Management CRDM at Medtronic from 2002 to 2006.
Ms. Groves additionally has extensive experience in strategic business consulting, including significant strategy development and M&A engagements for McKinsey & Company, Inc. Her background also includes significant involvement with start-up companies and direct financial planning and reporting in numerous aspects of health care, including direct providers.
